Products for Research Use Only

NG2 binding peptide

CAT: 0804-HY-P10989Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10989Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
NG2 binding peptide is a short peptide that specifically recognizes NG2 proteoglycan and can be obtained by phage screening technology. NG2 binding peptide interacts with NG2 binding sites to achieve precise targeting of tumor angiogenesis in vitro and in vivo. NG2 binding peptide exhibits significant homing ability in wild-type tumor-bearing mice, but has no localization effect in NG2 knockout mice. Due to the tissue specificity of NG2 expression, NG2 binding peptide can be used in scenarios such as tumor targeted therapy, drug delivery, and molecular imaging diagnosis[1].
CAS Number
241478-23-9
UNSPSC
12352209
Target
Others
Related Pathways
Others
Field of Research
Cancer
Smiles
O=C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CO)C(NCC(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CO)C(N[C@@H](CCSC)C(N[C@@H](CC1=CNC=N1)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H]([C@H](O)C)N
Molecular Formula
C40H69N15O14S
Molecular Weight
1016.13
References & Citations
[1]Burg MA, et al. NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res. 1999 Jun 15;59 (12) :2869-74.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported